Javad Javidnia

Dr. Javad Javidnia

Mazandaran University of Medical Sciences, Sārī, Māzandarān, Iran
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
MMMahboobeh Montazeri
Mahboobeh Montazeri
TGTahereh Mikaeili Galeh
Tahereh Mikaeili Galeh
MMMahmood Moosazadeh
Mahmood Moosazadeh
SSShahabeddin Sarvi
Shahabeddin Sarvi
SDSamira Dodangeh
Samira Dodangeh
ADAhmad Daryani
Ahmad Daryani
Background: Felids (domestic and wild cats) are important in the epidemiology of the parasite Toxoplasma gondii because they are the only hosts that can excrete the environmentally resistant oocysts. We conducted a systematic review and meta-analysis to estimate the global prevalence of T. gondii in species of the family Felidae. Methods: We searched seven databases (PubMed, Embase, Google Scholar, ScienceDirect, Scopus, Proquest and Web of Science) for studies reporting seroprevalence of T. gondii in felids from 1967 to 31 December 2017. A total of 217 published papers, containing 223 datasets were eligible for inclusion in the meta-analysis, comprised 59,517 domestic and 2733 wild cats from 1967 to 2017. Results: The pooled global T. gondii seroprevalence was estimated to be 35% (95% CI: 32–38%) and 59% (95% CI: 56–63%) in domestic cats and wild felids, respectively, using random effects model. The seroprevalence was higher in Australia and Africa where the T. gondii seropositivity in domestic cats was 52% (95% CI: 15–89%) and 51% (95% CI: 20–81%), respectively. The lowest seroprevalence was estimated in Asia 27% (95% CI: 24–30%). The seroprevalence values for T. gondii in wild felids were 74% (95% CI: 62–83%) in Africa, 67% (95% CI: 23–111%) in Asia, 67% (95% CI: 58–75%) in Europe and 66% (95% CI: 41–91%) in South America. Conclusions: Our study provides the global prevalence of T. gondii in species of the family Felidae and is a source of information to aid public health workers in developing prevention plans.

5 November 2018 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
SHSeyyed Abdollah Hosseini
Seyyed Abdollah Hosseini
AAA. Amouei
A. Amouei
MSM. Sharif
M. Sharif
SSSh. Sarvi
Sh. Sarvi
LGL. Galal
L. Galal
ADAhmad Daryani
Ahmad Daryani
Toxoplasma gondii (T. gondii) as an obligate intracellular protozoan with a worldwide distribution can infect virtually all warm-blooded animals and humans. This study aims to provide a summary of the available data on genotypes of T. gondii in human. Five databases including MEDLINE in PubMed, Scopus, Science Direct, Web of Science and Google Scholar were searched for the T. gondii genotyping in human during 1995–August 2017. Next, we screened all the articles based on the inclusion and exclusion criteria. Overall, 26 studies were eligible regarding genotyping T. gondii in human samples. In clonal genotyping, 167 out of 286 cases (58%) were infected with type II. Genetic characterisation of T. gondii isolates displayed that type II was the most predominant genotype in human with the prevalence of 64.3%, 62.1% and 41.7% in patients with AIDS, congenital and ocular toxoplasmosis, respectively. In ToxoDB genotyping, most individuals were infected with genotypes #9 and #65 (21.2%). Based on these results, genotype profile of T. gondii isolates is different throughout the world. The strains in Asian and African countries are characterised by low genetic diversity, while in North and South America a wide diversity of this parasite is found. In countries without any data (e.g. Australia, Western and Southern Africa and Western Asia), identification of T. gondii genotypes might discover higher genetic diversity.

1 September 2020 in New Microbes and New Infections
Verified
Journal Article
Open access
FPF. Pourali
F. Pourali
MAM. Afshari
M. Afshari
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
Javad JavidniaJavad Javidnia
Javad Javidnia
MMMahmood Moosazadeh
Mahmood Moosazadeh
AHA. Hessami
A. Hessami
The relationship between ABO blood group and the incidence of coronavirus disease 2019 (COVID-19) infection and death has been investigated in several studies. The reported results were controversial, so the objective of the present study was to assess the relationship between different blood groups and the onset and mortality of COVID-19 infection using a meta-analysis method. We searched relevant databases using appropriate MeSH terms. We screened articles on the bases of titles, abstracts and full text, and articles that met the inclusion criteria were selected. Quality assessment was done with the Newcastle-Ottawa scale checklist. The estimated frequency of COVID-19 infection and death in terms of ABO blood group and the overall estimate of the odds ratio between blood group with COVID-19 infection and death was calculated with 95% confidence interval. The pooled frequency of blood groups A, B, O and AB among COVID-19–infected individuals was estimated as 36.22%, 24.99%, 29.67% and 9.29% respectively. The frequency of blood groups A, B, O and AB among patients who died of COVID-19 infection was estimated as 40%, 23%, 29% and 8% respectively. The odds ratio of COVID-19 infection for blood group A versus the other blood groups was estimated as 1.16 (95% confidence interval (CI), 1.02–1.33). The corresponding figures for blood groups O and AB versus other blood groups were estimated as 0.73 (95% CI, 0.60–0.88) and 1.25 (95% CI, 0.84–1.86) respectively. This meta-analysis showed that individuals with blood group A are at higher risk for COVID-19 infection while those with blood group O are at lower risk. Although the odds ratio of death for AB blood group was nonsignificant, it was considerable.

29 August 2019 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
AAAfsaneh Amouei
Afsaneh Amouei
SSShahabeddin Sarvi
Shahabeddin Sarvi
MSMehdi Sharif
Mehdi Sharif
SASargis Aghayan
Sargis Aghayan
Javad JavidniaJavad Javidnia
Javad Javidnia
ADAhmad Daryani
Ahmad Daryani

1 December 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
KDKambiz Diba
Kambiz Diba
KMKhadijeh Makhdoomi
Khadijeh Makhdoomi
ENElahe Nasri
Elahe Nasri
AVAfsane Vaezi
Afsane Vaezi
Javad JavidniaJavad Javidnia
Javad Javidnia
HFHamed Fakhim
Hamed Fakhim

1 March 2018 in Journal of Medical Mycology
Verified
Journal Article
Closed access
AVA. Vaezi
A. Vaezi
HFH. Fakhim
H. Fakhim
Javad JavidniaJavad Javidnia
Javad Javidnia
SKSadegh Khodavaisy
Sadegh Khodavaisy
ZAZ. Abtahian
Z. Abtahian
Hamid BadaliHamid Badali
Hamid Badali